Aortic cannula disruption following long-term LVAD support.

Area of Science:

• Cardiovascular Medicine
• Biomedical Engineering
• Medical Devices

Background:

• The Levitronix CentriMag is a paracorporeal ventricular assist device approved in Europe for short-term use (up to 30 days) in acute heart failure.
• It serves as a bridge to recovery, heart transplantation, or long-term mechanical circulatory support.
• Indications include uni- or biventricular support.

Observation:

• A case report details a patient requiring extended support with the Levitronix CentriMag pump for 119 days.
• This prolonged duration was necessitated by an anatomical condition preventing device exchange.
• The pump head and circuit components remained unchanged throughout the support period.

Findings:

• The Levitronix CentriMag pump demonstrated mechanical reliability, with no impeller failure observed during the 119-day support period.
• The patient's adverse outcome was attributed to the rupture of a cannula, not a malfunction of the pump itself.
• This represents the first reported failure of a short-term paracorporeal ventricular assist device due to cannula disruption.

Implications:

• This case highlights the potential for extended use of short-term ventricular assist devices beyond their approved duration, contingent on device integrity.
• It underscores the critical importance of cannula integrity and proper management in paracorporeal mechanical circulatory support systems.
• Further investigation into cannula durability and failure modes in prolonged VAD support is warranted.